The life sciences industry has one of the strongest M&A markets in recent history. Read what Crosstree managing directors Shane Senior, Jeff Ellis, and Zeke Navar have to say about investment prospects in pharma services, pharma IT, lab services, and digital health in February’s edition of PharmaVOICE.
Fueled by the strong financial performance of Pharma Services, Diagnostics and Tools, and Digital Health companies and accelerated by the COVID-19 pandemic, the life sciences industry currently has one of the strongest M&A markets in recent history. Read the full article in PharmaVOICE or download a PDF of the article.
